Company Analysis

vTv Therapeutics Inc. (VTVT)

Nasdaq: VTVT · Pharmaceutical Preparations · High Point, NC · filing with the SEC since 2015
Grade5.3
◀ Past 3.4● Present 4.8▶ Future 6.9
5 est.

Who runs vTv Therapeutics Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Sekhri Paul J
Pres, CEO and Exec Chairperson. First filing Aug 2022, latest Feb 18, 2026, 1 filing in all.
Officers reporting now
2
of 12 people with a filing in the last fifteen months
Directors reporting now
10
33 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Sekhri Paul JPres, CEO and Exec ChairpersonAug 2022Feb 18, 2026none
Tung Michael StephenEVP & CFOMay 2025Feb 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
667, L.P.directorMar 2024Jun 29, 2026none
Akkaraju SrinivasdirectorFeb 2024Jun 29, 2026none
Al-Marzooqi FaheddirectorJun 2022Jun 29, 2026none
Baker Bros. Advisors (Gp) LLCdirectorMar 2024Jun 29, 2026none
Baker Bros. Advisors LPdirectorMar 2024Jun 29, 2026none
Baker Brothers Life Sciences LPdirectorMar 2024Jun 29, 2026none
Baker FelixdirectorMar 2024Jun 29, 2026none
Baker JuliandirectorMar 2024Jun 29, 2026none
Phillips Anne M.directorMar 2024Jun 29, 2026none
Spiegelman Daniel KdirectorJun 2024Jun 29, 2026none
Earlier names on the record25, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VTVT · research, not advice